Paras Healthcare IPO Subscription: What Investors Are Buying in the Hospital Group
The Paras Healthcare IPO subscription closed at 2.34 times. A look at the hospital business, the profit turnaround and the offer structure.
The Paras Healthcare IPO subscription closed at 2.34 times. A look at the hospital business, the profit turnaround and the offer structure.
What Talkiatry therapy services nationwide mean for patients on psychiatric medication: coverage, claims, and the questions still unanswered.
What the healthcare AI adoption survey 2026 means for hospital leaders: 91% want AI training, but a quarter lack clear governance. A checklist.
The FDA prescription drug software guidance gives sponsors a decision tree for apps and labeling. A plain-language walk-through and what is unclear.
The Redesign Health ARC Global merger comes with a planned AVIA acquisition. What is disclosed on terms, leadership and valuation, and what is not.
The BD Alaris infusion set FDA alert reaches hospitals through Cardinal Health Presource kits. What procurement and supply teams need to know.
The global healthcare AI regulatory network shares real-time warnings on harmful AI incidents. What Poland joining means for patient safety and oversight.
The Roche Q3 2026 results beat forecasts, while giredestrant, fenebrutinib and a reported Hansoh deal shape how Roche plans to replace expiring products.
The US Ebola travel declaration is the latest step after May and July entry bars. A timeline of the rules, what changes on 3 November and what is unknown.